Published in Nephrol Dial Transplant on January 01, 1996
Severe hyponatraemia: investigation and management in a district general hospital. J Clin Pathol (2002) 1.63
Acute kidney injury by radiographic contrast media: pathogenesis and prevention. Biomed Res Int (2014) 0.93
Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors. ScientificWorldJournal (2014) 0.90
Knockout of Ku86 accelerates cellular senescence induced by high NaCl. Aging (Albany NY) (2009) 0.82
The potential use of biomarkers in predicting contrast-induced acute kidney injury. Int J Nephrol Renovasc Dis (2016) 0.77
Update on the renal toxicity of iodinated contrast drugs used in clinical medicine. Drug Healthc Patient Saf (2017) 0.75
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol (1998) 2.55
Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. Am J Kidney Dis (2001) 2.49
BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Am J Hum Genet (2000) 2.31
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism. J Clin Endocrinol Metab (2007) 1.93
Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia. Blood (1998) 1.71
Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood (1996) 1.59
Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. Eur J Endocrinol (1999) 1.51
Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities? Ann Oncol (1995) 1.49
Thyrotropin receptor mutations and thyroid hyperfunctioning adenomas ten years after their first discovery: unresolved questions. Thyroid (2003) 1.46
Testing Sokal's and the new prognostic score for chronic myeloid leukaemia treated with alpha-interferon. Italian Cooperative Study Group on Chronic Myeloid Leukaemia. Br J Haematol (2000) 1.46
Antiproteinuric effect of Losartan in patients with chronic renal diseases. Nephrol Dial Transplant (1997) 1.41
Heat-induced unfolding of neocarzinostatin, a small all-beta protein investigated by small-angle X-ray scattering. J Mol Biol (2001) 1.41
A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia. Haematologica (1999) 1.39
Fetal proteins and chronic treatment with low-dose erythropoietin. J Lab Clin Med (1997) 1.37
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol (1995) 1.36
Current indications for renal biopsy: a questionnaire-based survey. Am J Kidney Dis (2000) 1.31
An insertion in the human thyrotropin receptor critical for high affinity hormone binding. Science (1990) 1.21
The Kell blood group system: Kell and XK membrane proteins. Semin Hematol (2000) 1.20
Bortezomib as an antitumor agent. Curr Pharm Biotechnol (2006) 1.17
Expression of pendrin and the Pendred syndrome (PDS) gene in human thyroid tissues. J Clin Endocrinol Metab (2000) 1.15
Patient-controlled analgesia in children and adolescents: a randomized, prospective comparison with intramuscular administration of morphine for postoperative analgesia. J Pediatr (1991) 1.15
Staging and prognosis in chronic myelogenous leukemia. Semin Hematol (1988) 1.15
Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function. Proc Natl Acad Sci U S A (1991) 1.15
Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab (1997) 1.13
Proteolytic processing of big endothelin-3 by the kell blood group protein. Blood (1999) 1.10
Radiation sensitivity of human lung cancer cell lines. Eur J Cancer Clin Oncol (1989) 1.10
Rituximab for myasthenia gravis developing after bone marrow transplant. Neurology (2000) 1.10
Iodide symporter gene expression in human thyroid tumors. J Clin Endocrinol Metab (1998) 1.08
ESPEN Guidelines on Parenteral Nutrition: adult renal failure. Clin Nutr (2009) 1.07
Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease: a prospective long-term cardiac magnetic resonance imaging study. Heart (2009) 1.07
Gross hematuria of uncommon origin: the nutcracker syndrome. Am J Kidney Dis (1998) 1.06
The psychosocial impact of multiple sclerosis: exploring the patient's perspective. Health Psychol (1999) 1.05
Percutaneous ethanol injection efficacy in the treatment of large symptomatic thyroid cystic nodules: ten-year follow-up of a large series. Thyroid (2002) 1.04
Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors. Eur J Endocrinol (2001) 1.03
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. Am J Kidney Dis (1999) 1.02
[Fabry nephropathy in a female with superposed IgA glomerulonephritis]. G Ital Nefrol (2005) 0.98
Graves' disease, thyroid nodules and thyroid cancer. Clin Endocrinol (Oxf) (2001) 0.98
Sodium iodide symporter expression and radioiodine distribution in extrathyroidal tissues. J Endocrinol Invest (2004) 0.98
Expert working group report on nutrition in adult patients with renal insufficiency (Part 2 of 2). Clin Nutr (2000) 0.97
Polycystin-1 interacts with intermediate filaments. J Biol Chem (2001) 0.97
A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia. Clin Infect Dis (2001) 0.97
Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects. Kidney Int (2001) 0.97
Notch signaling is involved in expression of thyrocyte differentiation markers and is down-regulated in thyroid tumors. J Clin Endocrinol Metab (2008) 0.97
Resistance of natural killer T cell-deficient mice to systemic Shwartzman reaction. J Exp Med (2000) 0.96
Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis. Mult Scler (1999) 0.95
Photodynamic therapy of ascites tumours within the peritoneal cavity. Br J Cancer (1986) 0.94
Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors. J Clin Invest (1991) 0.94
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin. Pharmacogenomics J (2012) 0.94
Investigation of the presence of ghrelin in the central nervous system of the rat and mouse. Neuroscience (2011) 0.93
Role of plasma vasopressin in the impairment of water excretion in nephrotic syndrome. Kidney Int (1984) 0.93
Serine-threonine protein kinase Akt does not mediate ischemic tolerance after global ischemia in the gerbil. J Cereb Blood Flow Metab (2000) 0.92
Effects of water hardness on urinary risk factors for kidney stones in patients with idiopathic nephrolithiasis. Nephron (1999) 0.92
Endocrine dysfunction in patients with Fabry disease. J Clin Endocrinol Metab (2006) 0.90
Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis. J Infect Dis (1994) 0.90
17beta-estradiol synthesis in the adult male rat retina. Exp Eye Res (2007) 0.90
Cellular components and tunic architecture of the solitary ascidian Styela canopus (Stolidobranchiata, Styelidae). Tissue Cell (1998) 0.90
Role of renal biopsy in the diagnosis and prognosis of acute renal failure. Kidney Int Suppl (1998) 0.89
Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen. J Lab Clin Med (1986) 0.89
Functional analysis of the cytoplasmic domains of the human thyrotropin receptor by site-directed mutagenesis. J Biol Chem (1990) 0.89
Prognostic significance of normal quantitative planar thallium-201 stress scintigraphy in patients with chest pain. J Am Coll Cardiol (1985) 0.89
Caveat to genotype-phenotype correlation in mucopolysaccharidosis type II: discordant clinical severity of R468W and R468Q mutations of the iduronate-2-sulfatase gene. Hum Mutat (1993) 0.89
Renal adaptation to dietary sodium restriction in moderate renal failure resulting from chronic glomerular disease. J Am Soc Nephrol (1996) 0.89
[Health-related quality of life in patients with chronic kidney disease]. G Ital Nefrol (2008) 0.88
Effects of a mixture of polychlorinated biphenyls (Aroclor 1254) on the transcriptional activity of thyroid hormone receptor. J Endocrinol Invest (2003) 0.88
Carotid endarterectomy with contralateral carotid artery occlusion: is this a higher risk subgroup? Eur J Vasc Endovasc Surg (2002) 0.88
Expert Working Group report on nutrition in adult patients with renal insufficiency (part 1 of 2). Clin Nutr (2000) 0.88
Kinetics of Th1/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective study. Bone Marrow Transplant (2009) 0.88
Extracellular domain chimeras of the TSH and LH/CG receptors reveal the mid-region (amino acids 171-260) to play a vital role in high affinity TSH binding. Biochem Biophys Res Commun (1990) 0.87
Downregulation of cell survival signalling pathways and increased cell damage in hydrogen peroxide-treated human renal proximal tubular cells by alpha-erythropoietin. Cell Prolif (2009) 0.87
Eleven amino acids (Lys-201 to Lys-211) and 9 amino acids (Gly-222 to Leu-230) in the human thyrotropin receptor are involved in ligand binding. J Biol Chem (1991) 0.87
All-trans retinoic acid in hematological malignancies, an update. GER (Gruppo Ematologico Retinoidi). Haematologica (1997) 0.87
Scleroembolization for treatment of hypertension caused by intrarenal arterial fibrodysplasia. Clin Nephrol (1984) 0.87
Rituximab for the treatment of type II mixed cryoglobulinemia. Haematologica (1999) 0.86
Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease. Clin Genet (2004) 0.86
The 3',5'-cyclic adenosine monophosphate response element binding protein (CREB) is functionally reduced in human toxic thyroid adenomas. Endocrinology (2000) 0.86
Iris indocyanine green videoangiography in diabetic iridopathy. Br J Ophthalmol (1996) 0.85
PRIMA-1 synergizes with adriamycin to induce cell death in non-small cell lung cancer cells. J Cell Biochem (2008) 0.85
Thyroid function in Fabry disease before and after enzyme replacement therapy. Minerva Endocrinol (2011) 0.85
Ectopic expression of FSH receptor isoforms in neoplastic but not in endothelial cells from pancreatic neuroendocrine tumors. J Endocrinol Invest (2012) 0.85
Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma. J Endocrinol Invest (1998) 0.85
Sodium-iodide symporter (NIS) gene expression in lymph-node metastases of papillary thyroid carcinomas. Eur J Endocrinol (2000) 0.85
Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivates. J Endocrinol Invest (2007) 0.85
Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects. Kidney Int (1989) 0.84
Liposome-encapsulated daunorubicin for PGP-related multidrug resistance. Br J Haematol (1999) 0.84
Neurosteroids in the retina: neurodegenerative and neuroprotective agents in retinal degeneration. Ann N Y Acad Sci (2003) 0.83
Mutations in the SLC26A4 (pendrin) gene in patients with sensorineural deafness and enlarged vestibular aqueduct. J Endocrinol Invest (2004) 0.83
Elastic incoherent neutron scattering as a probe of high pressure induced changes in protein flexibility. Biochim Biophys Acta (2009) 0.83
Early impairment of renal hemodynamic reserve in patients with asymptomatic heart failure is restored by angiotensin II antagonism. Circulation (1999) 0.83
Iodide symporter gene expression in normal and transformed rat thyroid cells. Eur J Endocrinol (1999) 0.83
Kell and XK immunohistochemistry in McLeod myopathy. Muscle Nerve (2001) 0.83
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients. Leukemia (2001) 0.83
Hepatitis C and kidney disease. Dig Liver Dis (2007) 0.83
Kell, Kx and the McLeod syndrome. Baillieres Best Pract Res Clin Haematol (1999) 0.82
Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients. Kidney Int (2000) 0.82
Mechanism of increased plasma urea after diuretic therapy in uraemic patients. Clin Sci (Lond) (1985) 0.82